Enanta Pharmaceuticals, Inc.
ENTA

$133.1 M
Marketcap
$6.28
Share price
Country
$0.42
Change (1 day)
$17.80
Year High
$5.70
Year Low
Categories

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

marketcap

Stock price history for Enanta Pharmaceuticals, Inc. (ENTA)

Highest end of day price: $126.37 USD on 2018-07-09

Lowest end of day price: $5.85 USD on 2024-12-18

Stock price history of Enanta Pharmaceuticals, Inc. from 2013 to 2024